Replies to post #11180 on Cytodyn Inc (CYDY)

[pearsby09]

GILD's Two Major Platforms are HCV, which is loosing traction, revenue and Profitability, and HIV, which is still somewhat intact. However, HIV is subject to patent expiration's in the next 12 to 18 months. PRO 140 could help fill that void.